ITRM
NASDAQ · Pharmaceuticals
Iterum Therapeutics Plc
$0.00
-0.03 (-99.68%)
Open$0.00
Previous Close$0.03
Day High$0.00
Day Low$0.00
52W High$0.71
52W Low—
Volume—
Avg Volume115.5K
Market Cap746.1K
P/E Ratio—
EPS$-0.75
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.84M | 2.52M | 2.36M |
| Net Income | 737.1K | 595.8K | 463.7K |
| Profit Margin | 25.9% | 23.7% | 19.6% |
| EBITDA | 1.27M | 1.08M | 1.08M |
| Free Cash Flow | 617.3K | 603.4K | 596.2K |
| Rev Growth | +5.6% | +6.9% | +16.3% |
| Debt/Equity | 0.35 | 0.29 | 0.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |